Literature DB >> 26393184

Comparison Between Dexmedetomidine and Propofol with Validation of Bispectral Index For Sedation in Mechanically Ventilated Intensive Care Patients.

Bharat Paliwal1, Pyush Rai2, Manoj Kamal3, Geeta Singariya3, Madhu Singhal4, Priyanka Gupta5, Tanuja Trivedi6, Dilip Singh Chouhan7.   

Abstract

BACKGROUND AND AIM: Sedation plays a pivotal role in the care of the critically ill patient. It is equally important to assess depth of sedation. The present study had been designed to compare dexmedetomidine and propofol for sedation in mechanically ventilated intensive care patients. It also intended to verify the clinical validity, reliability and applicability of objective assessment tool bispectral index (BIS) for monitoring sedation and observe for correlation with the commonly used subjective scale, Ramsay sedation score (RSS).
MATERIALS AND METHODS: This prospective randomized study was carried out in 60 haemodynamically stable patients, aged between 18 to 80 years, requiring sedation and mechanical ventilation. These were divided equally into two groups. Group A received dexmedetomidine loading dose (1μg/kg) over 10 min followed by maintenance infusion of 0.5μg/kg/hr (0.2-0.7 μg/kg/hr). Group B received propofol loading dose (1mg/kg) over 5 min followed by infusion of 2mg/kg/hr (1-3mg/kg/hr). All patients received fentanyl 1 μg/kg prior to the study drugs. Vital parameters and sedation levels (using RSS and BIS) were monitored for the study period of 12 hours with level 4 or 5 of RSS as target for sedation. Ramsay score was compared with the average of BIS values. Statistical analysis was done using SPSS VERSION 17 software.
RESULTS: The study revealed statistically significant lower heart rates during sedation in dexmedetomidine group whereas fall in mean arterial pressure (MAP) following loading dose in propofol group. Patients sedated with dexmedetomidine were easily arousable. Need for rescue drug for achieving the desired RSS as well as incidence of bradycardia was more in dexmedetomidine group than other. Good correlation exists between Ramsay score and BIS values.
CONCLUSION: Dexmedetomidine reduces heart rate while propofol transiently affects MAP. However, adequate sedation is achieved with both the drugs. The data obtained from the study validate BIS monitoring for ICU sedation.

Entities:  

Keywords:  Bispectral index (BIS); Dexmedetomidine; Propofol; Ramsay sedation score (RSS); Sedation in ICU

Year:  2015        PMID: 26393184      PMCID: PMC4573016          DOI: 10.7860/JCDR/2015/14474.6258

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  18 in total

Review 1.  Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens.

Authors:  A Shafer
Journal:  Crit Care Med       Date:  1998-05       Impact factor: 7.598

2.  Comparison of dexmedetomidine, propofol and midazolam for short-term sedation in postoperatively mechanically ventilated neurosurgical patients.

Authors:  Vinit K Srivastava; Sanjay Agrawal; Sanjay Kumar; Abhishek Mishra; Sunil Sharma; Raj Kumar
Journal:  J Clin Diagn Res       Date:  2014-09-20

3.  Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison.

Authors:  A A Weinbroum; P Halpern; V Rudick; P Sorkine; M Freedman; E Geller
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

4.  Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.

Authors:  J P Kress; A S Pohlman; M F O'Connor; J B Hall
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

5.  Assessing sedation during intensive care unit mechanical ventilation with the Bispectral Index and the Sedation-Agitation Scale.

Authors:  L E Simmons; R R Riker; B S Prato; G L Fraser
Journal:  Crit Care Med       Date:  1999-08       Impact factor: 7.598

6.  Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: haemodynamic effects and efficacy.

Authors:  M Ickeringill; Y Shehabi; H Adamson; U Ruettimann
Journal:  Anaesth Intensive Care       Date:  2004-12       Impact factor: 1.669

7.  Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.

Authors:  Richard R Riker; Yahya Shehabi; Paula M Bokesch; Daniel Ceraso; Wayne Wisemandle; Firas Koura; Patrick Whitten; Benjamin D Margolis; Daniel W Byrne; E Wesley Ely; Marcelo G Rocha
Journal:  JAMA       Date:  2009-02-02       Impact factor: 56.272

8.  Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit.

Authors:  Aliye Esmaoglu; Ayşe Ulgey; Aynur Akin; Adem Boyaci
Journal:  J Crit Care       Date:  2009-03-27       Impact factor: 3.425

Review 9.  Instruments for monitoring intensive care unit sedation.

Authors:  G Carrasco
Journal:  Crit Care       Date:  2000-07-13       Impact factor: 9.097

10.  Sedation in the intensive care setting.

Authors:  Christopher G Hughes; Stuart McGrane; Pratik P Pandharipande
Journal:  Clin Pharmacol       Date:  2012-10-25
View more
  4 in total

1.  Burst-suppression ratio underestimates absolute duration of electroencephalogram suppression compared with visual analysis of intraoperative electroencephalogram.

Authors:  W G Muhlhofer; R Zak; T Kamal; B Rizvi; L P Sands; M Yuan; X Zhang; J M Leung
Journal:  Br J Anaesth       Date:  2017-05-01       Impact factor: 9.166

2.  Efficacy of Dexmedetomidine versus Ketofol for Sedation of Postoperative Mechanically Ventilated Patients with Obstructive Sleep Apnea.

Authors:  Hatem Elmoutaz Mahmoud; Doaa Abou Elkassim Rashwan
Journal:  Crit Care Res Pract       Date:  2018-01-28

3.  Sedation effects by dexmedetomidine versus propofol in decreasing duration of mechanical ventilation after open heart surgery.

Authors:  Ahmed Said Elgebaly; Mohab Sabry
Journal:  Ann Card Anaesth       Date:  2018 Jul-Sep

4.  Verification of the performance of the Bispectral Index as a hypnotic depth indicator during dexmedetomidine sedation.

Authors:  Seunghee Ki; Dongeon Lee; Wonjin Lee; Kwangrae Cho; Yongjae Han; Jeonghan Lee
Journal:  Anesth Pain Med (Seoul)       Date:  2021-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.